DK607988A - 4-phenyl-4-(n-phenylamido)-piperidinderivater, optisk aktive isomere og farmaceutisk acceptable syreadditionssalte deraf samt deres anvendelse - Google Patents

4-phenyl-4-(n-phenylamido)-piperidinderivater, optisk aktive isomere og farmaceutisk acceptable syreadditionssalte deraf samt deres anvendelse

Info

Publication number
DK607988A
DK607988A DK607988A DK607988A DK607988A DK 607988 A DK607988 A DK 607988A DK 607988 A DK607988 A DK 607988A DK 607988 A DK607988 A DK 607988A DK 607988 A DK607988 A DK 607988A
Authority
DK
Denmark
Prior art keywords
phenylamido
phenyl
acid addition
addition salts
optically active
Prior art date
Application number
DK607988A
Other languages
English (en)
Other versions
DK607988D0 (da
DK172787B1 (da
Inventor
Linas V Kudzma
H Kenneth Spencer
Sherry A Severnak
Original Assignee
Boc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boc Inc filed Critical Boc Inc
Publication of DK607988D0 publication Critical patent/DK607988D0/da
Publication of DK607988A publication Critical patent/DK607988A/da
Application granted granted Critical
Publication of DK172787B1 publication Critical patent/DK172787B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK198806079A 1987-11-02 1988-11-01 4-Phenyl-4-(N-phenylamido)-piperidinderivater, optisk aktive isomere og farmaceutisk acceptable syreadditionssalte deraf sa DK172787B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11528487 1987-11-02
US07/115,284 US4791121A (en) 1987-11-02 1987-11-02 4-phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds

Publications (3)

Publication Number Publication Date
DK607988D0 DK607988D0 (da) 1988-11-01
DK607988A true DK607988A (da) 1989-05-03
DK172787B1 DK172787B1 (da) 1999-07-19

Family

ID=22360366

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806079A DK172787B1 (da) 1987-11-02 1988-11-01 4-Phenyl-4-(N-phenylamido)-piperidinderivater, optisk aktive isomere og farmaceutisk acceptable syreadditionssalte deraf sa

Country Status (16)

Country Link
US (1) US4791121A (da)
EP (1) EP0315405B1 (da)
JP (2) JPH02152963A (da)
KR (1) KR970008313B1 (da)
CN (1) CN1020723C (da)
AU (1) AU611728B2 (da)
CA (1) CA1334416C (da)
DE (1) DE3854938T2 (da)
DK (1) DK172787B1 (da)
ES (1) ES2081810T3 (da)
FI (1) FI885035L (da)
GR (1) GR3019342T3 (da)
IL (1) IL88140A0 (da)
MX (1) MX9203140A (da)
NO (1) NO172691C (da)
NZ (1) NZ226634A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871749A (en) * 1987-12-31 1989-10-03 Boc, Inc. 4-heteropentacyclic-4-(N-(phenyl)amido) piperidine derivatives and pharamaceutical compositions and method employing such compounds
US4868194A (en) * 1988-09-23 1989-09-19 Merrell Dow Pharmaceuticals Inc. Imidazole antiarrhythmics
KR900016129A (ko) * 1989-04-20 1990-11-12 테리 아아르 커세트 4-알콕시알킬-4-아미노페닐피페리딘 및 그들의 유도체의 제조 방법
US4939161A (en) * 1989-05-12 1990-07-03 Boc, Inc. Analgesic N-aryl-N-[1-substituted-3,5-dimethyl-4-piperidinyl]amides
FR2678267B1 (fr) * 1991-06-25 1994-02-04 Elf Sanofi Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2725986B1 (fr) * 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) * 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
AR028948A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
WO2007061555A1 (en) * 2005-11-17 2007-05-31 Mallinckrodt Inc. Process for synthesizing remifentanil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3161637A (en) * 1961-10-10 1964-12-15 Res Lab Dr C Janssen N V 1-(gamma-aroyl-propyl)-4-(nu-arylcarbonyl amino) piperidines and related compounds
NL284196A (da) * 1961-10-10
US3998834A (en) * 1975-03-14 1976-12-21 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-n-phenylamides and -carbamates
US4196210A (en) * 1975-09-23 1980-04-01 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne

Also Published As

Publication number Publication date
JPH0552834B2 (da) 1993-08-06
JPH0215061A (ja) 1990-01-18
NZ226634A (en) 1990-07-26
CN1041585A (zh) 1990-04-25
EP0315405B1 (en) 1996-01-24
NO884842L (no) 1989-05-03
CN1020723C (zh) 1993-05-19
ES2081810T3 (es) 1996-03-16
MX9203140A (es) 1992-07-01
FI885035A7 (fi) 1989-05-03
DE3854938T2 (de) 1996-05-30
IL88140A0 (en) 1989-06-30
FI885035L (fi) 1989-05-03
JPH02152963A (ja) 1990-06-12
KR890008094A (ko) 1989-07-08
EP0315405A1 (en) 1989-05-10
DE3854938D1 (de) 1996-03-07
KR970008313B1 (ko) 1997-05-23
US4791121A (en) 1988-12-13
GR3019342T3 (en) 1996-06-30
NO884842D0 (no) 1988-10-31
FI885035A0 (fi) 1988-11-01
AU2455888A (en) 1989-05-04
NO172691C (no) 1993-08-25
NO172691B (no) 1993-05-18
CA1334416C (en) 1995-02-14
DK607988D0 (da) 1988-11-01
AU611728B2 (en) 1991-06-20
DK172787B1 (da) 1999-07-19

Similar Documents

Publication Publication Date Title
DK617388D0 (da) Substituerede carboxylsyrederivater, deres fremstiilling og anvendelse som fungicider
DK49388A (da) N-heterocyclo-n-(4-piperidyl)-amider samt deres anvendelse som laegemidler
DK298984D0 (da) Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling
DK607988D0 (da) 4-phenyl-4-(n-phenylamido)-piperidinderivater, optisk aktive isomere og farmaceutisk acceptable syreadditionssalte deraf samt deres anvendelse
DK112287A (da) Anvendelse af 2-alkoxy-n-(1-azabicyclo-oe2,2,2aaoct-3-yl)-benzamider og -thiobenzamider samt farmaceutisk acceptable syreadditionssalte deraf som laegemidler
NO891749D0 (no) Syreaddisjonssalter, deres fremstilling og anvendelse.
DK131887D0 (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DK482688D0 (da) Substituerede 2-phenyl-4-quinolin-carboxylsyrer og deres anvendelse som laegemidler
DK165552C (da) Carboxylsyreestere, deres fremstilling og anvendelse som insecticider
DK513188A (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
DK179786D0 (da) (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK300583A (da) Racemiske eller optisk aktive eburnanoximderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK375689A (da) Isoxazolobenzoxazepiner, geometriske isomere, stereoisomere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK192588A (da) Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK299983D0 (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
DK523289A (da) 2,3,5,6-tetrahydro(1,3,6)triazocino(1,2-a)benzim- idazoler eller farmaceutisk acceptable syreadditionssalte deraf og deres anvendelse
DK576687D0 (da) Terapeutisk aktive alkensyrederivater
DK568584A (da) Azabicyclo(3,3,1)nonan-9-oner eller stereoisomere eller farmaceutiskacceptable syreadditionssalte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen
DK504386A (da) Gonadoliberinanaloge og farmaceutisk acceptable syreadditionssalte, deres fremstilling og anvendelse
DK513386D0 (da) Optisk aktive acyloxazetidinoner samt deres fremstilling og anvendelse
DK384184A (da) Cumalinsyreestere, deres fremstilling samt anvendelse som fungicider
DK325687A (da) Hydrogenerede 1-phenoxyalkylpyridin-3-carboxylsyreforbindelser og salte deraf samt deres fremstilling og anvendelse
DK514786D0 (da) 5-heterocyclyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner og tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelsesom antidepressive midler
IT1224503B (it) Derivati di acidi nucleici fisiologicamente attivi
DK453485D0 (da) 1,2,3,4,6,7,12,1rb-octahydroindolo-(2,3-a)quinolizin-1-yl-alkancarboxylsyreamider og farmaceutisk anvendelige syreadditionssalte deraf,deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK